Crohn's disease: open trials in Denmark

22 open trials have a site in Denmark. Registry data; only the trial team decides who can take part.

2024-518296-56-00
A clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Region Hovedstaden, Herlev · Odense University Hospital, Odense C
Registry updated 2026-11-05
NCT06937099
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Trial Treatment · Phase 3 · Eli Lilly and Company
Aarhus Universitetshospital, Skejby, Aarhus · Herlev and Gentofte Hospital, Copenhagen · Rigshospitalet, Copenhagen · Aalborg Universitetshospital, Syd, Gistrup · Odense Universitetshospital, Odense · Vejle Sygehus, Vejle
Registry updated 2026-11-04
NCT07499232
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Aarhus University Hospital, Aarhus C · Sydvestjysk Sygehus, Esbjerg · NAU New Aalborg University Hospital, Gistrup · Herlev Hospital, Herlev · Nordsjaellands Hospital, Hillerod, Hilleroed · Hvidovre Hospital, Hvidovre · Bispebjerg Hospital, København NV · Odense UH og Svendberg sygehus, Odense C
Registry updated 2026-11-03
NCT06233461
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 2 · Takeda
Esbjerg Og Grindsted Sygehus, Esbjerg · Region Nordjylland, Gistrup · Hillerod Hospital, Hilleroed · Hvidovre Hospital, Hvidovre · Region Sjaelland, Koege · Odense University Hospital, Odense C
Registry updated 2026-11-02
NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Region Hovedstaden, Herlev · Odense University Hospital, Odense C
Registry updated 2026-11-02
2025-522362-78-00
A study to measure mirikizumab levels in breast milk of lactating participants receiving mirikizumab therapeutically for an approved indication
Trial Treatment · Phase 4 · Eli Lilly & Co.
Region Midtjylland, Aarhus N · Slagelse Hospital, Slagelse
Registry updated 2026-10-30
NCT06819878
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Hoffmann-La Roche
Region Hovedstaden, Herlev
Registry updated 2026-10-16
2026-525197-19-00
A clinical trial to assess the efficacy and safety of ontunisertib compared to placebo in patients with fibrostenosing Crohn’s disease
Trial Treatment · Phase 2 · Agomab Spain S.L.U.
Region Midtjylland, Aarhus N · Copenhagen University Hospital, Copenhagen Nv · Rigshospitalet, Copenhagen Oe · Region Hovedstaden, Herlev · Region Syddanmark, Odense C
Registry updated 2026-10-14
NCT06405087
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Trial Treatment · Phase 3 · Takeda
Region Hovedstaden, Hvidovre
Registry updated 2026-10-09
NCT06548542
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Trial Treatment · Phase 2 · AbbVie
Aarhus University Hospital, Aarhus N · Copenhagen University Hospital, Copenhagen Nv · Odense University Hospital, Odense C
Registry updated 2026-09-25
NCT06882993
Feasibility of a Minimally Invasive Diagnostic Algorithm in Suspected Crohn's Disease
Trial Treatment · Esbjerg Hospital - University Hospital of Southern Denmark
Esbjerg Hospital, University Hospital of Southern Denmark, Esbjerg · Odense University Hospital, Odense C · Odense University Hospital - Svendborg Hospital, Svendborg · Lillebaelt Hospital Vejle, University Hospital of Southern Denmark, Vejle
Registry updated 2026-09-09
2025-521590-13-00
Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year
Trial Treatment · Phase 3 · Janssen Cilag International
Aalborg University Hospital, Aalborg · Region Midtjylland, Aarhus N · Copenhagen University Hospital, Copenhagen Nv · Rigshospitalet, Copenhagen Oe · Esbjerg Og Grindsted Sygehus, Esbjerg · Herlev Hospital, Herlev · Region Hovedstaden, Hilleroed · Region Hovedstaden, Hvidovre · Odense University Hospital, Odense C
Registry updated 2026-08-28
NCT06100289
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Trial Treatment · Phase 3 · Takeda
Hvidovre Hospital, Hvidovre
Registry updated 2026-08-03
NCT06227910
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Trial Treatment · Phase 3 · Takeda
Rigshospitalet, Copenhagen Oe · Region Nordjylland, Gistrup · Hvidovre Hospital, Hvidovre
Registry updated 2026-05-27
NCT06764615
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Trial Treatment · Phase 2 · Takeda
Aalborg University Hospital, Aalborg · Esbjerg Og Grindsted Sygehus, Esbjerg · Hillerod Hospital, Hilleroed · Region Hovedstaden, Hvidovre · Region Sjaelland, Koege · Odense University Hospital, Odense C
Registry updated 2026-05-22
NCT06257706
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
Trial Treatment · Phase 4 · Alimentiv Inc.
Region Midtjylland, Aarhus N · Copenhagen University Hospital, Copenhagen Nv · Region Hovedstaden, Herlev · Nordsjaellands Hospital, Hilleroed · Hvidovre Hospital, Hvidovre · Region Sjaelland, Koege · Region Midtjylland, Randers Noe
Registry updated 2026-01-15
NCT06324838
Extended Mesenteric Resection in Ileocecal Crohn's Disease.
Trial Treatment · Odense University Hospital
Odense University Hospital, Odense
Registry updated 2026-01-15
NCT07338565
Magnesium in Gastrointestinal Disease
Research · University of Aarhus
Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus N
Registry updated 2026-01-14
NCT04924270
Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases
Trial Treatment · Phase 2 · Odense University Hospital
Odense University Hospital, Odense
Registry updated 2025-12-05
NCT07240181
OPTImization of Inflammatory Bowel Disease Treatment Through Understanding of Gut VIRome Heterogeneity
Research · Andreas Munk Petersen
Hvidovre Hospital, Hvidovre
Registry updated 2025-11-20
NCT07113717
Post Operative Hospital at Home After Colorectal Surgery
Trial Treatment · Nordsjaellands Hospital
Department of Surgery, Hillerød
Registry updated 2025-08-11
NCT06788340
MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease
Trial Treatment · Phase 4 · Odense University Hospital
Aalborg University Hospital, Aalborg · Esbjerg Og Grindsted Sygehus, Esbjerg · Hvidovre Hospital, Hvidovre · Odense University Hospital, Nyborg · Odense University Hospital, Odense C · Sygehus Lillebaelt - Vejle Sygehus, Vejle
Registry updated 2025-07-31

All Crohn's disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error